HOME >> MEDICINE >> NEWS
Surgery to treat vocal-cord spasms shows high success rate

The first large, long-term study of patients who had surgery to control vocal-cord spasms showed excellent results in the majority of cases, reports new UCLA research presented May 14 at the 126th Annual Meeting of the American Laryngological Association.

"We are very encouraged by our results," said Dr. Dinesh Chhetri, assistant professor of head and neck surgery at the David Geffen School of Medicine at UCLA, who presented the findings. "When spasmodic dysphonia symptoms do not return within one year, they generally will not be coming back. Our findings suggest that this surgical technique provides the first permanent solution to treating the condition."

Spasmodic dysphonia is a neurological condition that disrupts nervous signals to the vocal cords, preventing them from vibrating properly. The voice is reduced to a strangled, broken whisper, interfering with a person's ability to communicate and enjoy a successful career and personal life. The disorder affects 50,000 people in the United States, and its cause remains unknown.

In 1989, the FDA approved the use of Botox injections into the vocal cords. Required every few months, these treatments temporarily relieve the symptoms, but not the disorder. At up to $2,000 a pop, the shots are pricey as well as uncomfortable and time-consuming. Some patients also can develop Botox resistance.

In 1993, Dr. Gerald Berke, chief of head and neck surgery at the David Geffen School of Medicine at UCLA, pioneered the first surgery to permanently treat spasmodic dysphonia symptoms. The surgeon severs the nerve sending abnormal signals to the vocal cords, and then attaches a healthy nerve from the throat to maintain the vocal cords' muscle tone.

Chhetri and his colleagues surveyed 131 patients at an average of four years post-surgery. Eighty-one patients completed the questionnaire. Of these patients, 91 percent expressed greater satisfaction with their vocal quality post-surger
'"/>

Contact: Elaine Schmidt
eschmidt@mednet.ucla.edu
310-794-2272
University of California - Los Angeles
14-May-2005


Page: 1 2 3

Related medicine news :

1. Surgery by satellite -- New possibilities at medicines cutting edge
2. UCLA surgeon honored with American Association for Thoracic Surgerys Achievement Award
3. Mayo Clinic Cancer Center -- Surgery and adjuvant therapy may work for pancreatic cancer
4. Springer debuts Journal of Robotic Surgery
5. Plastic Surgery 2006 spotlights the future of plastic surgery
6. Springer acquires Obesity Surgery from FD-Communications
7. Journal of Gastrointestinal Surgery added to Springers growing medical program
8. Northwestern Memorial Hospital named Bariatric Surgery Society Center of Excellence
9. The Emotional First Aid + Kit: A Practical Guide to Life After Bariatric Surgery
10. Surgery can ease sleep problems for those with brain malformations
11. Surgery enters virtual world

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Surgery treat vocal cord spasms shows high success rate

(Date:1/23/2015)... AZ (PRWEB) January 23, 2015 Hastings and ... injury matters, reports a record number of legal representation client ... speaking, there has been a steady rise in the number ... work and at home throughout the Valley. With that said, ... accident be reviewed by an experienced law firm. Hastings and ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
(Date:1/23/2015)... 23, 2015  MedScope ( www.medscope.org ), the leading provider ... 2015 Connected World magazine Connected World Award ... that can be used anywhere, anytime. The nomination was ... In nominating MedScope, Landon Garner , Director ...
(Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: